New concepts on the immune modulation mediated by mesenchymal stem cells

被引:102
作者
Bunnell, Bruce A. [1 ,2 ,3 ]
Betancourt, Aline M. [1 ,4 ]
Sullivan, Deborah E. [1 ,4 ]
机构
[1] Tulane Univ, Sch Med, Ctr Stem Cell Res & Regenerat Med, New Orleans, LA 70112 USA
[2] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA
[3] Tulane Natl Primate Res Ctr, Div Gene Therapy, New Orleans, LA 70112 USA
[4] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA
基金
美国国家卫生研究院;
关键词
TOLL-LIKE RECEPTORS; MARROW STROMAL CELLS; ADULT STEM/PROGENITOR CELLS; INTER-ALPHA-INHIBITOR; IMMUNOSUPPRESSIVE PROPERTIES; IFN-GAMMA; IN-VITRO; T-CELLS; TRANSPLANTATION; MACROPHAGES;
D O I
10.1186/scrt34
中图分类号
Q813 [细胞工程];
学科分类号
100113 [医学细胞生物学];
摘要
Mesenchymal stem cells (MSCs) are the nonhematopoietic multipotent progenitor cells found in various adult tissues. They are characterized by their ease of isolation and their rapid growth in vitro while maintaining their differentiation potential, allowing for extensive expansion in culture that yields large quantities suitable for therapeutic use. This article reviews the immunomodulatory activities associated with MSCs. Numerous studies have demonstrated that MSCs are potently immunosuppressive in vitro and in vivo. However, this article presents a new paradigm in MSC biology, in which MSCs, at least in vitro, can undergo polarization into either a pro-inflammatory or an immunosuppressive phenotype.
引用
收藏
页数:8
相关论文
共 88 条
[1]
Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[2]
Signaling danger:: Toll-like receptors and their potential roles in kidney disease [J].
Anders, HJ ;
Banas, B ;
Schlöndorff, D .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (04) :854-867
[3]
Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness [J].
Beyth, S ;
Borovsky, Z ;
Mevorach, D ;
Liebergall, M ;
Gazit, Z ;
Aslan, H ;
Galun, E ;
Rachmilewitz, J .
BLOOD, 2005, 105 (05) :2214-2219
[4]
Mesenchymal stem cells: Revisiting history, concepts, and assays [J].
Bianco, Paolo ;
Robey, Pamela Gehron ;
Simmons, Paul J. .
CELL STEM CELL, 2008, 2 (04) :313-319
[5]
Why are MSCs therapeutic? New data: new insight [J].
Caplan, Al .
JOURNAL OF PATHOLOGY, 2009, 217 (02) :318-324
[6]
Mesenchymal stem cells as trophic mediators [J].
Caplan, Arnold I. ;
Dennis, James E. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 98 (05) :1076-1084
[7]
Caplan AI, 2009, TISSUE ENG PART B-RE, V15, P195, DOI [10.1089/ten.teb.2008.0515, 10.1089/ten.TEB.2008.0515]
[8]
Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism [J].
Chen, Ke ;
Wang, Ding ;
Du, Wei Ting ;
Han, Zhi-Bo ;
Ren, He ;
Chi, Ying ;
Yang, Shao Guang ;
Zhu, Delin ;
Bayard, Francis ;
Han, Zhong Chao .
CLINICAL IMMUNOLOGY, 2010, 135 (03) :448-458
[9]
Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing [J].
Chen, Liwen ;
Tredget, Edward E. ;
Wu, Philip Y. G. ;
Wu, Yaojiong .
PLOS ONE, 2008, 3 (04)
[10]
Role of toll-like receptors on human adipose-derived stromal cells [J].
Cho, Hyun Hwa ;
Bae, Yong Chan ;
Jung, Jin Sup .
STEM CELLS, 2006, 24 (12) :2744-2752